-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on 10x Genomics, Raises Price Target to $22

Benzinga·12/15/2025 20:54:22
語音播報
Barclays analyst Luke Sergott maintains 10x Genomics (NASDAQ:TXG) with a Overweight and raises the price target from $17 to $22.